Bimekizumab-Treated Patients with Active Psoriatic Arthritis Showed Sustained Improvements in Pain and Fatigue: Up to 2-Year Results from Two Phase 3 Studies

被引：0
|
作者：
Mease, Philip [1 ,2 ]
Tillett, William [3 ,4 ]
de Wit, Maarten [5 ]
Gossec, Laure [6 ]
Husni, M. Elaine [7 ]
Proft, Fabian [9 ,10 ]
Ink, Barbara [8 ,11 ]
Bajracharya, Rajan [11 ]
Coarse, Jason [12 ]
Lambert, Jeremy [13 ]
Coates, Laura [14 ]
Gottlieb, Alice [15 ]
机构：
[1] Providence St Joseph Hlth, Swedish Med Ctr, Seattle, WA USA
[2] Univ Washington, Sch Med, Seattle, WA USA
[3] Royal Natl Hosp Rheumat Dis, Bath, England
[4] Univ Bath, Dept Life Sci, Ctr Therapeut Innovat, Bath, England
[5] Stichting Tools, Patient Res Partner, Amsterdam, Netherlands
[6] Sorbonne Univ, Paris, France
[7] Cleveland Clin, Cleveland, OH USA
[8] Charite Univ Med Berlin, Berlin, Germany
[9] Free Univ Berlin, Berlin, Germany
[10] Humboldt Univ, Berlin, Germany
[11] UCB Pharma, Slough, England
[12] UCB Pharma, Morrisville, NC USA
[13] UCB Pharma, Colombes, France
[14] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England
[15] Icahn Sch Med Mt Sinai, Dept Dermatol, Seattle, WA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2368
引用
收藏
页码：4789 / 4792
页数：4
相关论文
共 50 条
  • [1] Bimekizumab-treated patients with active psoriatic arthritis showed sustained achievement of minimal disease activity and remission: Up to 2-year results from two phase 3 studies
    Coates, L. C.
    Kristensen, L. E.
    Ogdie, A.
    Tillett, W.
    Ink, B.
    Goldammer, N.
    Bajracharya, R.
    Coarse, J.
    Orbai, A. M.
    SWISS MEDICAL WEEKLY, 2024, 154 : 35S - 35S
  • [2] Bimekizumab-Treated Patients with Active Psoriatic Arthritis Showed Sustained Reductions in Disease Impact Assessed by the Psoriatic Arthritis Impact of Disease (PsAID)-12 Questionnaire: Up to 2-Year Results from Two Phase 3 Studies
    Gossec, Laure
    Gladman, Dafna
    Coates, Laura
    de Wit, Maarten
    Ink, Barbara
    Bajracharya, Rajan
    Coarse, Jason
    Lambert, Jeremy
    Orbai, Ana-Maria
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1228 - 1232
  • [3] BIMEKIZUMAB DELIVERED SUSTAINED IMPROVEMENTS IN EFFICACY AND DEMONSTRATED A CONSISTENT SAFETY PROFILE IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: UP TO 2-YEAR RESULTS FROM TWO PHASE 3 STUDIES
    Mease, P. J.
    Merola, J. F.
    Landewe, R.
    McInnes, I. B.
    Ritchlin, C. T.
    Tanaka, Y.
    Asahina, A.
    Gossec, L.
    Ink, B.
    Heinrichs, A.
    Bajracharya, R.
    Shende, V
    Coarse, J.
    Coates, L. C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (09) : 98 - 99
  • [4] Bimekizumab Maintained Efficacy Responses in Patients with Active Psoriatic Arthritis: Up to 2-Year Results from Two Phase 3 Studies
    Walsh, Jessica A.
    Merola, Joseph F.
    Ritchlin, Christopher T.
    Tanaka, Yoshiya
    Favalli, Ennio Giulio
    McGonagle, Dennis
    Thaci, Diamant
    Ink, Barbara
    Bajracharya, Rajan
    Coarse, Jason
    Tillett, William
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1206 - 1209
  • [5] BIMEKIZUMAB EFFICACY AND SAFETY IN PATIENTS WITH PSORIATIC ARTHRITIS AND PSORIASIS: UP TO 2-YEAR RESULTS FROM TWO PHASE 3 STUDIES
    Thaci, Diamant
    Gottlieb, Alice B.
    Asahina, Akihiko
    Lebwohl, Mark
    McInnes, Iain B.
    Warren, Richard
    Boehncke, Wolf-Henning
    Ink, Barbara
    Bajracharya, Rajan
    Coarse, Jason
    Merola, Joseph F.
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [6] BIMEKIZUMAB REDUCED PSORIATIC ARTHRITIS IMPACT IN PATIENTS WITH PSORIASIS: UP TO 2-YEAR RESULTS FROM TWO PHASE 3 STUDIES
    Gossec, Laure
    Gladman, Dafna D.
    Gisondi, Paolo
    de Wit, Maarten
    Ogdie, Alexis
    Ink, Barbara
    Taieb, Vanessa
    Lambert, Jeremy
    Coates, Laura C.
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [7] Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies
    Mease, Philip J.
    Merola, Joseph F.
    Tanaka, Yoshiya
    Gossec, Laure
    Mcinnes, Iain B.
    Ritchlin, Christopher T.
    Landewe, Robert B. M.
    Asahina, Akihiko
    Ink, Barbara
    Heinrichs, Andrea
    Bajracharya, Rajan
    Shende, Vishvesh
    Coarse, Jason
    Coates, Laura C.
    RHEUMATOLOGY AND THERAPY, 2024, 11 (05) : 1363 - 1382
  • [8] Sustained improvements with bimekizumab in patientreported symptoms of axial spondyloarthritis: 2-year results from two phase 3 studies
    Marzo-Ortega, H.
    Mease, P. J.
    Dougados, M.
    Dubreuil, M.
    Magrey, M.
    Rudwaleit, M.
    D'Agostino, M. A.
    de la Loge, C.
    Fleurinck, C.
    Massow, U.
    Taieb, V
    Deodhar, A.
    SWISS MEDICAL WEEKLY, 2024, 154 : 34S - 34S
  • [9] Sustained Improvements with Bimekizumab in Patient-Reported Symptoms of Axial Spondyloarthritis: 2-Year Results from Two Phase 3 Studies
    Marzo-Ortega, Helena
    Mease, Philip
    Dougados, Maxime
    Dubreuil, Maureen
    Magrey, Marina
    Rudwaleit, Martin
    D'Agostino, Maria Antonietta
    de la Loge, Christine
    Massow, Ute
    Taieb, Vanessa
    Voiniciuc, Diana
    Deodhar, Atul
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1209 - 1213
  • [10] Bimekizumab-Treated Patients with Active PsA Showed Sustained Improvement in Disease Symptoms Assessed by the PsA Impact of Disease (PsAID)-12 Questionnaire: 1-Year Results Reported from Two Phase 3 Studies
    Gladman, Dafna
    Coates, Laura
    de Wit, Maarten
    Ogdie, Alexis R.
    Orbai, Ana-Maria
    Ink, Barbara
    Taieb, Vanessa
    Lambert, Jeremy
    Gossec, Laure
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4449 - 4452
12345